ulcerative colitis

Innovent’s trial of picankibart for ulcerative colitis meets primary endpoint
Clinical Trials Arena
Thu, 10/17/24 - 09:36 am
Innovent Biologics
ulcerative colitis
picankibart
clinical trials
FDA expands J&J's psoriasis drug for inflammatory bowel disease
Reuters
Wed, 09/11/24 - 10:59 pm
JNJ
Tremfya
FDA
ulcerative colitis
AbbVie’s Skyrizi Wins EU Nod for Ulcerative Colitis, Helps to Weather Humira Patent Cliff
BioSpace
Mon, 07/29/24 - 10:31 am
AbbVie
Europe
Skyrizi
ulcerative colitis
FDA approves Abbvie's Skyrizi for ulcerative colitis
PR Newswire
Tue, 06/18/24 - 07:56 pm
AbbVie
FDA
Skyrizi
ulcerative colitis
Where competition is heating up in pharma
Pharma Voice
Fri, 05/24/24 - 11:06 am
competition
oncology
immunology
COPD
RSV
ulcerative colitis
GSK
JNJ
Moderna Therapeutics
AltruBio lands up to $225M after shift to immune drug research
BioPharma Dive
Tue, 05/21/24 - 11:18 am
AltruBio
funding
ulcerative colitis
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena
Tue, 05/21/24 - 11:17 am
JNJ
Tremfya
ulcerative colitis
clinical trials
Pfizer’s Velsipity UK approval to raise competition in ulcerative colitis market
Biopharma Reporter
Mon, 04/15/24 - 11:11 am
Pfizer
Velsipity
UK
ulcerative colitis
Johnson & Johnson files sBLA for ulcerative colitis treatment
Pharmaceutical Business Review
Tue, 03/12/24 - 11:19 am
JNJ
FDA
Tremfya
ulcerative colitis
Biora’s BT-600 novel drug-device may revolutionise targeted colon therapy
Biopharma Reporter
Thu, 02/22/24 - 11:39 am
Biora Therapeutics
clinical trials
BTZ-600
drug-device combos
ulcerative colitis
Alfasigma to acquire Galapagos’ Jyseleca business
Pharmaceutical Business Review
Tue, 01/2/24 - 09:58 am
Galapagos
Alfasigma
Jyseleca
filgotinib
ulcerative colitis
rheumatoid arthritis
Insilico’s AI-discovered ulcerative colitis drug starts Phase I trial
Clinical Trials Arena
Thu, 12/7/23 - 10:13 am
Insilico
ulcerative colitis
clinical trials
NCT06012578
Eli Lilly Just Added Another Potential Billion-Dollar Product
Motley Fool
Sun, 11/5/23 - 11:08 pm
Eli Lilly
ulcerative colitis
Omvoh
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
Motley Fool
Sun, 10/29/23 - 08:44 pm
Roche
Eli Lilly
Pfizer
IBD
ulcerative colitis
Crohn's Disease
mirikizumab
Lilly’s ulcerative colitis therapy mirikizumab finally snags FDA approval
BioSpace
Fri, 10/27/23 - 11:54 am
Eli Lilly
ulcerative colitis
mirikizumab
Biora submits updated IND application for ulcerative colitis drug/device trial
Clinical Trials Arena
Tue, 10/24/23 - 09:37 am
Biora Therapeutics
ulcerative colitis
BT-600
FDA
drug-device combos
FDA approves Celltrion’s subcutaneous Remicade biosimilar for IBD
Pharm
Mon, 10/23/23 - 05:20 pm
Celltrio
Zymfentra
ulcerative colitis
Crohn's Disease
biosimilars
Remicade
Roche pays $7.1B to Roivant for rights to Telavant’s IBD candidate
BioSpace
Mon, 10/23/23 - 10:35 am
Roche
M&A
Televant
Roivant
RVT-3101
IBD
ulcerative colitis
Crohn’s disease
Pfizer takes aim at BMS' first-in-class Zeposia with FDA nod for ulcerative colitis drug Velsipity
Fierce Pharma
Fri, 10/13/23 - 10:35 am
Bristol Myers Squibb
Zeposia
Pfizer
Velsipity
etrasimod
ulcerative colitis
FDA
Ventyx Biosciences reports data from ulcerative colitis drug trial
Clinical Trials Arena
Tue, 10/10/23 - 10:08 am
Ventyx Biosciences
ulcerative colitis
VTX002
clinical trials

Pages